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Abstract
This study describes the effects of IL-1 (interleukin 1) and LPS (bacterial endotoxin lipopolysaccharide) on 
the release of a-MSH (alpha melanocyte stimulating hormone) from the neurointermediate lobe (NIL) of the 
teleost Oreochromis mossambicus (tilapia). In vivo treatment of tilapia with IL-1 for 8 days led to a 49% 
inhibition of basal a-MSH release, measured by means of an in vitro micro-superfusion technique. The treat­
ment did not affect the sensitivity of the tissue to TRH. In vitro, the release of a-MSH was inhibited by LPS 
in a dose dependent manner. In addition to its effects on the unstimulated release of the hormone, LPS also 
blunted the response to a TRH stimulation. Together with recent results obtained by others demonstrating 
the effects of (neuro-)peptides on immune parameters and the presence of cytokines in fish, the present data 
establish the bidirectional character of the communication between the immune and the (neuro-)endocrine 
systems in teleosts.
Résumé
Cette étude décrit les effets de 1TL-1 (interleukin 1) et du LPS (bacterial endotoxin lipopolysaccharide) sur 
la libération de a-MSH (alpha melanocyte stimulating hormone) par le lobe neurointermédiaire (NIL) d ’un 
téléosteen Oreochromis mossambicus (tilapia). Le traitement in vivo du tilapia avec PIL-1 pendent 8 jours 
conduit à une inhibition de 49% de la libération basale d ’a-MSH mesurée à l’aide d ’une technique in vitro 
de micro-superfusion. Ce traitement ne modifie pas la sensibilité du tissue au TRH. In vitro, la libération 
de a-M SH est inhibée par le LPS de manière dose-dépendante. En plus de ses effets sur la libération basale 
de a-M SH, le LPS bloque aussi la réponse à une stimulation par le TRH. Confrontés à des donnés récemment 
publiés montrant les effets de (neuro-)peptides sur les paramètres immunitaires et la présence de cytokines 
chez les poissons, nos résultats établissent le caractère bidirectionnel de la communication entre le système 
immunitaire et les systèmes (neuro-)endocriniens.
Introduction
It has become increasingly evident recently that 
adaptive regulation to a broad range of environ­
mental challenges relies on the communication be­
tween various regulatory systems. One of these 
challenges that calls for an integrated response is a 
bacterial infection. This is illustrated by the fact
126
that the immunological defense mechanism act con­
currently with an activation of the adrenal axis in 
mammals (Besedovski and Sorkin 1977; Blalock 
1989). These events can be mimicked experimental­
ly by administration of LPS (bacterial endotoxin 
lipolysaccharide) or cytokines such as interleukin 1 
(IL-1) to animals. The activation of the adrenal axis 
results from coordinated actions of messengers of 
the immune system on central (hypothalamus) and 
peripheral (pituitary and adrenal) levels (Hermus 
and Sweep 1990). Knowledge about these mechan­
isms in teleosts is fragmentary, but evidence sug­
gests that in fish too, LPS administration results in 
elevated cortisol levels (White and Fletcher 1984). 
Furthermore, immune functions in teleosts are sen­
sitive to stressors (Maule et al. 1989). The present 
study describes the effects of IL-1 and LPS on the 
release of cv-MSH from the pituitary of freshwater 
tilapia (Oreochromis mossambicus). Recently, a- 
MSH has been implicated in neuroimmunological 
models, mainly as an antagonist of IL-1 dependent 
actions (Daynes et al. 1987; Robertson et al. 1988). 
In addition, in fish, a-MSH is a potent stimulator 
of interrenal cortisol production (Balm et al. 1987).
Materials and methods
Animals
Male tilapia (Oreochromis mossambicus), body 
weights ranging from 10 to 30 g), were obtained 
from our laboratory stock. They were kept in fresh­
water aquaria on a neutral background and on a 
12L/12D light-regime. The fish were fed tropical 
fish food (Tetramin).
In vivo IL-1 treatment
Groups of 12 fish (25 ± 1 g) were injected i.p. on
4 alternate days with either 20 fi\ saline (controls), 
or 20 ¡jl\  IL-1 (3 ng/g body weight). IL-1 was recom­
binant murine IL-1 a. from Genzyme Corporation 
(Boston USA; specific activity 14U/ng). One day 
after the last injection the animals were quickly net­
ted from their aquaria and killed by spinal dissec­
tion. The pituitaries were dissected out and placed 
in incubation medium.
In vitro superfusion o f  neurointermediate lobes
Superfusion of NILs was carried out as described 
previously (Lamers et al. 1991). Briefly, NILs were 
separated from the rostral pars distalis and trans­
ferred to chambers (10 ¡A\ 2 NILs per chamber) and 
superfused with incubation medium by means of a 
peristaltic multichannel pump (Watson Marlow). 
Fractions were collected with an ISCO fraction col­
lector and kept at - 2 0 ° C  until a-MSH assay by 
RIA (van Zoest et al. 1989). At selected intervals the 
tissue was treated with LPS (Escherichia coli, sero­
type 0111: B4, Sigma) and /o r  TRH (Peninsula 
Laboratories).
Statistics
Data are presented as means ± SEM. In vitro 
release rates were calculated as pg a-MSH* 
min-1*NIL_1. Differences between control and in 
vitro treated lobes were assessed by subjecting these 
data to the Mann-Whitney U test, taking the aver­
age value of 3 fractions just prior to each pulse as 
the control value and taking the maximally stimu­
lated or inhibited fraction as the second experimen­
tal value for each individual lobe. The in vitro LPS 
effect, obtained from various separate experi­
ments, is presented as % of control values for com­
parison’s sake. Symbols used indicate: * 0.02 <  p
<  0.05; ** 0.01 <  p <  0.02; *** 0.001 <  p <  0.01 
and **** p < 0.001.
Results
In vivo treatment of tilapia with IL-1 markedly in­
hibited a-M SH release as indicated by the in vitro 
release of the hormone from the neurointermediate 
lobe. The initial in vitro release rate (first fraction, 
0 -3 0  min) was inhibited 64% in the IL-1 group 
(707 ± 96 pg-m in^-lobe“ 1 vs. 257 ± 45 pg. 
min“ 1*lobe“ 1; p <  0.01). With time, the release
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Fig. I. In vitro release o f  a -M S H  by neurointermediate  lobes from control tilapia and  from fish pretreated with IL -1 in vivo. The average 
body weight o f  the fish was 25 ±  1 g (n = 24). NILs were pulsed for 30 min with 2 .10~8 M T R H .
30
cl
i
G
►
e
CbO
CL
(A
2 5
20
15
0 5 0 1 0 0  1 5 0  2 0 0  2 5 0  3 0 0  3 5 0  4 0 0
t im e (min)
Fig. 2. The effect o f  3 doses o f  LPS (E. coli 0 1 1 1:B4) in vitro on the release o f  a -M S H  by NILs from control tilapia. Data  are from
4 individual incubations; the fish used weighed 12 ±  2 g (n =  8).
rates declined to base-line levels which were inhibit- release of a-M SH in both groups, and the degree of 
ed 49% in the treated group (Fig. 1; p <  0.01). A stimulation was identical in both cases (260 ± 15% 
40 min pulse with TRH significantly stimulated the vs. 287 ±  52%). The lobe content of a-M SH, deter-
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Table I . Effect o f  LPS on in vitro cx-MSH release.
Concentra t ion  LPS 
(¿ig-ml-1)
% Inhibition Significance
0.1 6 ±  1 ***
1 21 ± 3 * * * *
5 36 ±  5 * * * *
15 49 ±  7 ****
50 87 ± 3 ****
Means ±  SEM (n =  8). Percentages inhibition are calculated 
from the maximal inhibition observed during 40 min pulses, tak ­
ing the release rates just prior to the pulse as control (100a/o).
mined after the in vitro superfusion, was slightly 
higher in the IL-1 group: 72 ± 9 vs. 104 ± 23 
ng*NIL-1 (not statistically different).
LPS, when given in vitro, inhibited the release of 
a-MSH (Fig. 2); maximal inhibition occurred in the 
second 10 min fractions of the pulse periods. The 
effect was dose dependent as demonstrated in Table 
1: the minimum effective concentration was 1 
¿ig/ml (Table 1), whereas at the highest concentra­
tion tested (50 ¿tg/ml) the inhibition was 87 ± 3% 
(p < 0.001). Figure 3 demonstrates that in vitro 
LPS treatment not only inhibited the unstimulated 
a-MSH release (72% in this experiment), but also 
inhibited the sensitivity to TRH: the maximal 
stimulation in the control group was 520 ± 84% (n 
= 6) versus 270 ± 55% (n = 6) for the LPS 
pretreated NILs (TRH stimulation over baseline 
release in absolute values: 99 ± 25 pg*min-1 . 
NIL-1 for the controls, and 26 ± 8 
pg-min_1-NIL-1 for the LPS group; p <  0.05).
Discussion
The present data demonstrate for the first time the 
existence of neuro-immunological mechanisms 
regulating the release of a pituitary hormone in 
teleosts. The modulation of the release of a-MSH 
by IL-1 and LPS ties in with recent findings in 
higher vertebrates demonstrating immunomodula­
tory actions of the peptide (Cannon et al. 1986; 
Mason and van Epps 1989). It becomes apparent 
therefore that a-MSH in teleosts is not merely a 
hormone involved in background adaptation.
Previously we demonstrated the potency of a-MSH 
to stimulate interrenal cortisol production (Balm et 
al. 1987).
The inhibition of the release of a-MSH after 8 
days of in vivo treatment was evident during the en­
tire period studied in vitro, and could not be 
ascribed to a shortage of hormone, since after su­
perfusion the lobes of the IL-1 treated fish con­
tained slightly more a-MSH. An IL-1 like factor 
has been reported in fish, together with IL-1 like ef­
fects on immune parameters in teleosts (Sigel et al. 
1986). In mammals it has been demonstrated that 
a-MSH can antagonize II-1 dependent immune 
functions (Daynes et al. 1987; Robertson et al. 
1988). It might be suggested that the inhibition of 
the release of the hormone observed in the present 
study will serve to further enhance the biological ef­
fect of the cytokine. An interesting finding in this 
respect was reported by Sumner and Doudoroff in 
1938: fish on a black background (with high cir­
culating levels of a-MSH) are more prone to infec­
tions than animals on white backgrounds. To estab­
lish whether or not the IL-1 effect on a-MSH 
release could have been caused by a direct effect at 
the pituitary level we subsequently treated neuroin­
termediate lobes of control fish in vitro with LPS. 
It has been demonstrated in mammals that LPS in 
vitro stimulates the local production of IL-1 (Koe­
nig et al. 1990). The advantage of using LPS, rather 
than IL-1 lies in the kinetics of the in vitro effect on 
hormone release; IL-1 effects in vitro generally can­
not be detected within hours, whereas LPS effects 
occur much faster. To our knowledge the LPS ef­
fect presented is the first demonstration of an in 
vitro effect of lipopolysaccharides on a-M SH 
release in vertebrates. In mammals, LPS in vitro af­
fects the release of a number of hormones including 
growth hormone, ACTH, and prolactin. At present 
little is known about the mechanisms underlying 
the actions of LPS and IL-1, in particular in fish. 
The effects observed most likely do not demon­
strate a (cyto-)toxic action of LPS, since it has been 
reported that teleosts can tolerate these prepara­
tions much better (up to a thousandfold, Berczi et 
al. 1966) than higher vertebrates. Two other sugges­
tions are worth considering at this stage. Firstly, it 
has been suggested that one of the mechanisms
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Fig. 3. The effect o f  in vitro LPS pre trea tment  on the sensitivity o f  tilapia NIL  a -M S H  release to T R H  (30 min, 10-8 M; n =  6 for 
both groups).  Basal a -M S H  release (t = 125') was 27 ± 3 pg -m in -^ ' -N IL -1 (n =  12), and  body weight o f  the fish used was 15 ± 3 g.
through which LPS alters pituitary hormone release 
in mammals is the modulation of noradrenalin 
release from nerve terminals at the median emi­
nence, thereby modifying the release of messengers 
of hypothalamic origin (Elenkov et al. 1992). In 
teleosts these messengers are released in the prox­
imity of the hormone producing cells in the 
pituitary. This release persists during the first hours 
in vitro (Yu and Peter 1992), and one of the possible 
mechanisms mediating the LPS induced inhibition 
observed here might be the modulation of the 
release of neurotransmitters regulating a-MSH 
release. Secondly, the LPS signal might be mediat­
ed by (folliculo-)stellate cells in the pituitary. It has 
been reported that the mammalian pituitary stellate 
cells produce cytokines (Vankelecom et al. 1989), a 
process that can be manipulated by LPS in vitro. 
The cytokines produced are known to regulate en­
docrine cells in the pituitary (Spangelo et al. 1989). 
These mechanisms might also operate in lower ver­
tebrates, since it has been demonstrated at our 
department recently that a factor(s) produced by 
stellate cells regulate the a?-MSH release in Xenopus 
laevis (de Koning et al. 1991).
An important feature of the effects of LPS and 
cytokines is the modulation of the sensitivity of en­
docrine cells to secretagogues. This phenomenon is 
presently demonstrated in the case of LPS, but was 
not observed upon in vivo treatment of fish with 
IL-1. This difference could be the result of the 
release of other messengers by LPS, in addition to 
IL-1; in particular IL-6 (Spangelo et al. 1990) 
and /o r  tumor necrosis factor (TNF) might serve as 
candidates.
In summary, we demonstrate the inhibitory ac­
tion of LPS on the pituitary a-MSH release in tila­
pia, and evidence suggest that this action might at 
least be partly mediated by IL-1. Together with re­
cent results obtained by others demonstrating the 
effects of (neuro-)peptides on immune parameters 
and the presence of cytokines in teleosts (Bayne and 
Levy 1991; Sigel et al. 1986; Graham and Secombes 
1988), our data establish the bidirectional character 
of the communication between the (neuro-)endo- 
crine and the immune systems in teleosts.
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